3 unchanged sentences
001-38079), filed with the SEC on May 18, 2017).
−Removed: Pre-Paid Forward Contract by and among the Registrant and RTW Investments ICAV for and on behalf of RTW Fund 2, dated as of March 18, 2021, as amended April 30, 2021 and August 14, 2024.
−Removed: Separation Agreement between the Company and Don Kim, dated October 7, 2024 ( incorporated by reference to Exhibit 10.1 to the Registrant ’s Current Report on Form 8-K (File No.
−Removed: 001-38079 ), filed with the SEC on October 9, 2024 ).
−Removed: Employment Agreement between the Company and Chris Degnan, dated October 7, 2024 (incorporated by reference to Exhibit 10.2 to the Registrant ’s Quarterly Report on form 10-Q (File No.
−Removed: 001-38079 ), filed with the SEC on October 9, 2024) .
+Added: Asset Purchase Agreement by and among the Registrant and IconOVir Bio, Inc., dated as of February 14, 2025, as amended March 18, 2025.
Certification of Principal Executive Officer pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
16 unchanged sentences
UroGen Pharma Ltd.
−Removed: November 6, 2024
/s/ Elizabeth Barrett
2 unchanged sentences
(Principal Executive Officer)
−Removed: November 6, 2024
/s/ Chris Degnan
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.